Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods. (TOH-HTIC)
Acute or chronic liver failure (fulminant hepatitis or advanced cirrhosis) disrupts brain physiology. Beyond classical hepatic encephalopathy, intracranial hypertension may occur.During liver transplantation (LT) surgery, many factors can lead to cerebral assault. In addition, intracranial hypertension measured with invasive methods has been described in certain phases of LT, especially at the time of reperfusion.
The invasive monitoring of the intracranial pressure is not used in these patients, due to a high risk of infection and bleeding. The non-invasive monitoring of intracranial pressure has been widely developed in recent years : transcranial doppler and recently ultrasound of the optic nerve sheath (ONSD) allow an effective detection of intracranial hypertension.
Visão geral do estudo
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Lyon, França, 69004
- Département d'anesthésie réanimation
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients ≥ 18 years
- Patients who underwent orthotopic liver transplantation
- Patients who have received clear information and not opposed to participate in the study
- Patients affiliated to a social security scheme or similar
- Patients not undergoing a measure of legal protection
Exclusion Criteria:
- Opposition to participation in the study
- Patients < 18 years
- Pregnant women or breastfeeding
- Deprived of individual liberty
- Non-affiliated to a social security scheme
- Known ophthalmic pathology: untreated cataracts, glaucoma
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Patients undergoing liver transplantation
|
Ultrasound measurements of the optic nerve sheath diameter and intracranial Doppler, at 4 time points during surgery (incision, anhepatic phase + 30 min, declamping + 5 min, declamping + 30 min), and at day 1 and day 5 after surgery, to detect presence of intracranial hypertension. Search of any neurological complication during the 5 postoperative days. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Measure of the optic nerve sheath diameter during surgery.
Prazo: at incision
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at incision
|
|
Measure of the optic nerve sheath diameter during surgery.
Prazo: at anhepatic phase + 30 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at anhepatic phase + 30 min
|
|
Measure of the optic nerve sheath diameter during surgery.
Prazo: at declamping + 5 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at declamping + 5 min
|
|
Measure of the optic nerve sheath diameter during surgery.
Prazo: at declamping + 30 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at declamping + 30 min
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Prazo: at incision
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at incision
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Prazo: at anhepatic phase + 30 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at anhepatic phase + 30 min
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Prazo: at declamping + 5 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at declamping + 5 min
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Prazo: at declamping + 30 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at declamping + 30 min
|
|
Measurement of intracranial hypertension with transcranial Doppler
Prazo: at 1 day after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 1 day after surgery.
|
|
Measure of the optic nerve sheath diameter after surgery.
Prazo: at 1 day after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 1 day after surgery.
|
|
Measurement of intracranial hypertension with transcranial Doppler
Prazo: at 5 days after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 5 days after surgery.
|
|
Measure of the optic nerve sheath diameter after surgery.
Prazo: at 5 days after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 5 days after surgery.
|
|
The early appearance of neurological complications after surgery.
Prazo: During the 5 days following surgery
|
A monitoring with simultaneous collection of clinical, biological and ultrasound parameters, will be done.
Neurological complications after surgery will be defined by the presence of at least one of the following criteria: Glasgow score < 14 in a non-sedated patient, behavioral disorders, agitation (evaluation according to the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score), epilepsy, imaging or MRI scan.
Pathological evolved compared to the preoperative including hemorrhagic or thrombotic cardiovascular event.
Various confounding factors will be considered (serum sodium, serum tacrolimus, serum magnesium, ammonia, sedatives).
|
During the 5 days following surgery
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Mathieu GAZON, MD, Hospices Civils de Lyon
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 69HCL15_0483
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Ultrasound
-
Dr. Linda McLeanOttawa Hospital Research Institute; The Ottawa HospitalInscrevendo-se por convite
-
Seno Medical Instruments Inc.Concluído
-
University of British ColumbiaConcluído
-
Helse Nord-Trøndelag HFNorwegian University of Science and TechnologyConcluídoDerrame | Ataque isquêmico transitório | Ataque Isquêmico Transitório | Acidente vascular cerebral | Apoplexia | Apoplexia CerebrovascularNoruega
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ConcluídoVariabilidade inter e intraobservador nas medições Doppler da artéria uterina no primeiro trimestre.Medição Doppler da Artéria UterinaHolanda
-
Ottawa Hospital Research InstituteConcluído
-
Medical Corps, Israel Defense ForceRecrutamentoTrauma | Ferida HemorrágicaIsrael
-
University of British ColumbiaConcluído
-
Riverside University Health System Medical CenterDesconhecidoPacientes que estão em choque e intubados no Trauma Bay (TB)Estados Unidos
-
Helse Nord-Trøndelag HFNorwegian University of Science and Technology; St. Olavs HospitalConcluídoDerrame | Ataque isquêmico transitório | Ataque Isquêmico Transitório | Acidente vascular cerebral | Apoplexia CerebrovascularNoruega